| A distinct phylogenetic cluster of Indian severe acute respiratory syndrome coronavirus 2 isolates S Banu, B Jolly, P Mukherjee, P Singh, S Khan, L Zaveri, S Shambhavi, ... Open forum infectious diseases 7 (11), ofaa434, 2020 | 48 | 2020 |
| Cycling to meet fate: connecting pluripotency to the cell cycle L Zaveri, J Dhawan Frontiers in cell and developmental biology 6, 57, 2018 | 47 | 2018 |
| A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates S Banu, B Jolly, P Mukherjee, P Singh, S Khan, L Zaveri, S Shambhavi, ... BioRxiv, 2020.05. 31.126136, 2020 | 33 | 2020 |
| Evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection without mutations in the spike protein O Kulkarni, S Narreddy, L Zaveri, IG Kalal, KB Tallapaka, DT Sowpati Clinical Infectious Diseases 73 (5), e1239-e1241, 2021 | 15 | 2021 |
| Clinical outcomes in vaccinated individuals hospitalized with Delta variant of SARS-CoV-2 V Jagadeesh Kumar, DT Sowpati, A Munigela, S Banu, AB Siva, ... MedRxiv, 2021.07. 13.21260417, 2021 | 10 | 2021 |
| Host transcriptional response to SARS‐CoV‐2 infection in COVID‐19 patients NK Singh, S Srivastava, L Zaveri, TC Bingi, R Mesipogu, S Kumar, N Gaur, ... Clinical and Translational Medicine 11 (9), 2021 | 9 | 2021 |
| Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B. 1.617. 2) who had been vaccinated with COVISHIELD (ChAdOx1) and COVAXIN (BBV-152) A Munigela, DT Sowpati, M Sasikala, S Banu, AB Siva, C Nutalapati, ... IJID regions 5, 104-110, 2022 | 3 | 2022 |
| Clinical outcomes in Covishield (ChAdOx1) and Covaxin (BBV-152) vaccinated individuals hospitalized with the Delta variant (B. 1.617. 2) A Munigela, D Sowpati, S Banu, A Siva, C Nutalapati, R Vishnubhotla, ... IJID Regions (Online), 2022 | 1 | 2022 |
| Inducible expression of Oct-3/4 reveals synergy with Klf4 in targeting Cyclin A2 to enhance proliferation during early reprogramming L Zaveri, J Dhawan Biochemical and Biophysical Research Communications 587, 29-35, 2022 | 1 | 2022 |
| Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, India L Zaveri, R Singh, P Basu, S Banu, P Mukherjee, S Vishwakarma, ... MedRxiv, 2021.09. 19.21262487, 2021 | 1 | 2021 |
| NEMO: Improved and accurate models for identification of 6mA using Nanopore sequencing OV Kulkarni, L Zaveri, NK Singh, RJ Mathew, S Ara, S Garde, M Reddy, ... bioRxiv, 2024.03. 12.584205, 2024 | | 2024 |
| Evidence of SARS-CoV-2 reinfection without mutations in Spike protein. O Kulkarni, S Narreddy, L Zaveri, IG Kalal, KB Tallapaka, DT Sowpati Clinical Infectious Diseases: An Official Publication of the Infectious …, 2021 | | 2021 |
| Clinical outcomes in vaccinated individuals hospitalized with Delta variant of SARS-CoV-2 (preprint) DT Sowpati, A Munigela, S Banu, AB Siva, M Sasikala, C Nutalapati, ... | | 2021 |
| Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, India (preprint) L Zaveri, R Singh, P Basu, S Banu, P Mukherjee, S Vishwakarma, ... | | 2021 |
| Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients (preprint) NK Singh, S Srivastava, L Zaveri, TC Bingi, R Mesipogu, S Kumar, N Gaur, ... | | 2021 |
| A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates (preprint) S Banu, B Jolly, P Mukherjee, P Singh, S Khan, L Zaveri, S Shambhavi, ... | | 2020 |
| Clinical outcomes in vaccinated individuals hospitalized with Delta variant of SARS-CoV-2 F MWGO, A FJGES | | |
